Related content

Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients

By Gaviani Paola  

Journal of Neuro-Oncology, Vol. 104, Iss. 2, 2011-09 ,pp. : 617-618

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma

By Santoni Matteo  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 397-401

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma

By Addeo Raffaele   Caraglia Michele   Santi M.   Montella Liliana   Abbruzzese Alberto   Parlato Ciro   Vincenzi Bruno   Carraturo Marco   Faiola Vincenzo   Genovese Michele   Cennamo Gregorio   Prete Salvatore  

Journal of Neuro-Oncology, Vol. 102, Iss. 3, 2011-05 ,pp. : 425-425

Springer Publishing Company

Access to resources Recommend Favorite

A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma

By Addeo Raffaele   Caraglia Michele   Santi M.   Montella Liliana   Abbruzzese Alberto   Parlato Ciro   Vincenzi Bruno   Carraturo Marco   Faiola Vincenzo   Genovese Michele   Cennamo Gregorio   Prete Salvatore  

Journal of Neuro-Oncology, Vol. 102, Iss. 3, 2011-05 ,pp. : 417-424

Springer Publishing Company

Access to resources Recommend Favorite

Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme?

By Gallo Chiara   Buonerba Carlo   Lorenzo Giuseppe   Romeo Valeria   Placido Sabino   Marinelli Alfredo  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 311-319

Springer Publishing Company

Access to resources Recommend Favorite